Coeptis Therapeutics Inc. is a forward-thinking biopharmaceutical company based in Wexford, Pennsylvania, specializing in the development and commercialization of innovative cancer therapies that blend branded and generic pharmaceuticals with advanced cell therapy platforms. With a strong commitment to addressing significant unmet medical needs in oncology, Coeptis aims to enhance treatment outcomes and improve the quality of life for patients. The company's strategic emphasis on rigorous research and development positions it as a key player in the competitive cancer therapeutics market, highlighting its potential to deliver transformative solutions within the biopharmaceutical sector. Show more
Location: 105 BRADFORD ROAD, WEXFORD, PA, UNITED STATES, 15090, Wexford, PA, 15090, USA | Website: https://coeptistx.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE
Market Cap
68.21M
52 Wk Range
$6.26 - $21.41
Previous Close
$13.61
Open
$13.81
Volume
46,402
Day Range
$13.25 - $13.93
Enterprise Value
74.81M
Cash
4.908M
Avg Qtr Burn
-2.152M
Insider Ownership
9.42%
Institutional Own.
9.21%
Qtr Updated
06/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
DVX201 Details COVID-19 | Phase 1 Update |
